Myasthenic syndrome associated with antibiotics.
Myasthenic syndrome associated with antibiotics.
复制标题
与抗生素相关的肌无力综合征。
DOI:
10.1001/archneur.1968.00470340088008
复制
发表时间:
1968
期刊:
影响因子:
--
通讯作者:
J. O'Rourke
中科院分区:
文献类型:
--
作者:
M. Mcquillen;H. A. Cantor;J. O'Rourke
ANTIBIOTICS produce weakness by interfering with neuromuscular transmission. Apnea in experimental animals was observed first in 1941 with tyrothricin, the first antibiotic tested for clinical application. 1 In 1956, the first case of prolonged apnea in man was reported after intraperitoneally infected neomycin sulfate. 2 Since 1956, a syndrome characterized by respiratory weakness, flaccid paralysis, and pupillary and visual changes has been recognized in association with a number of antibiotics. 3-50 As defined, this "myasthenic syndrome" occurs in patients who do not have myasthenia gravis, although some myasthenics become weaker when given certain antibiotics. 51 Recent reviews of antibiotic toxicity do not emphasize this syndrome 52-54 Electromyographic (EMG) studies were mentioned in only four patients. In one, neuromuscular transmission and nerve conduction velocities were normal. 49 A "currarelike" 30 or nondepolarizing 34,50 effect occurred in the others. In one patient 50 the block was not altered by edrophonium chloride. Profound